Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentaglobin after source control in peritonitis
2016-001788-34Phase 2Active
- Sponsor
- University Hospital RWTH Aachen
- Start
- Jun 2017
- Modality
- Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Pentaglobin in peritonitis, sepsis and septic shock (2 arms), sponsored by University Hospital RWTH Aachen. Primary endpoint: Change in multiple organ failure score from baseline to day 7. Started Jun 2017; status: active.
02
Drugs
Pentaglobin
03
Conditions
peritonitissepsisseptic shock
Beyond the preview
Go deeper on 2016-001788-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001788-34.